Korean J Nephrol.  2001 Jan;20(1):143-146.

A Case of Reversible Posterior Leukoencepalopathy Syndrome during Steroid Therapy in a Down Syndrome with Nephrotic Syndrome

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Catholic University, Seoul, Korea. kbsnep@chollian.net
  • 2Department of Neurology, College of Medicine, Catholic University, Seoul, Korea.

Abstract

The reversible posterior leukoencephalopathy syndrome usually includes seizure, headache, altered mental status, and blindness, often associated with hypertension and immunosuppressants. The authors discuss a 16-year-old female with Down syndrome who had nephrotic syndrome with severe headache, intermittent blindness, and seizures, after treated with prednisolone. The patient had a generalized tonic-clonic seizure at 8 days after prednisolone. A CT scan of the head revealed symmetrical multifocal low densities in the subcortical region of both parieto-occipital, frontal, temporal lobe. Magnetic resonance scanning revealed white matter lesions in the subcortices of the parietal, frontal and occipital lobes. The condition improved when prednisolone was discontinued. Follow-up image after 3 weeks shows nearly complete resolution of white matter and gray matter abnormalities on axial T2-weighted MR images. This episode might be caused by prednisolone because the clinical course and laboratory data revealed neither inflammation nor other causative factors.

Keyword

Reversible posterior, leukoencepalopathy syndrome; Nephrotic syndrome; Steroid

MeSH Terms

Adolescent
Blindness
Down Syndrome*
Female
Follow-Up Studies
Head
Headache
Humans
Hypertension
Immunosuppressive Agents
Inflammation
Nephrotic Syndrome*
Occipital Lobe
Posterior Leukoencephalopathy Syndrome
Prednisolone
Rabeprazole
Seizures
Temporal Lobe
Tomography, X-Ray Computed
Immunosuppressive Agents
Prednisolone
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr